|
Synonyms: INOmax® | nitric oxide | nitrogen monoxide
NO is an approved drug (FDA (1999), EMA (2001))
Compound class:
Inorganic
Comment: Nitric oxide is a free radical and an important cellular signaling molecule involved in many physiological and pathological processes. The drugs nitroglycerin and amyl nitrite are nitric oxide precursors.
|
| Enzymes Catalysing Reactions with this Compound as a Substrate or Product | ||||||||||||||||
|
||||||||||||||||
| Selectivity at ion channels | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Selectivity at catalytic receptors | ||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
| Additional information and targets (data relate to human unless otherwise stated) | ||
| Description | Data | Reference |
| Endogenous inhibitors at adenylyl cyclase 6 | Gαi, Ca2+, PKA-evoked phosphorylation, PKC-evoked phosphorylation, NO | 1,5,8-10 |
| Endogenous inhibitors at adenylyl cyclase 5 | Gαi, Ca2+, PKA-evoked phosphorylation, Gβγ, NO | 3,5-7,9 |
| Endogenous ligand(s) at Guanylyl cyclase, α2β1 | NO | |
| Endogenous ligand(s) at Guanylyl cyclase, α1β1 | NO | |
| Other ligands which bind to or alter the activity of this ligand | ||||||||||||||||||||||||||||||||||||||||||||||
| Key to terms and symbols | Click column headers to sort | |||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||
| Ligand mentioned in the following text fields |
| Nitric oxide (NO)-sensitive (soluble) guanylyl cyclase overview |